Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Cash (2016 - 2025)

Anaptysbio filings provide 10 years of Change in Cash readings, the most recent being $128.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 287.39% year-over-year to $128.4 million, compared with a TTM value of $115.1 million through Dec 2025, up 32.14%, and an annual FY2025 reading of $115.1 million, up 32.14% over the prior year.
  • Change in Cash hit $128.4 million in Q4 2025 for Anaptysbio, up from $65.5 million in the prior quarter.
  • The five-year high for Change in Cash was $159.3 million in Q4 2021, with the low at -$329.3 million in Q1 2022.
  • Median Change in Cash over the past 5 years was $11.2 million (2022), compared with a mean of -$616000.0.
  • The sharpest move saw Change in Cash tumbled 1077.43% in 2022, then soared 1443.96% in 2024.
  • Year by year, Change in Cash stood at $159.3 million in 2021, then plummeted by 91.99% to $12.8 million in 2022, then fell by 24.22% to $9.7 million in 2023, then tumbled by 808.39% to -$68.5 million in 2024, then soared by 287.39% to $128.4 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $128.4 million, $65.5 million, and -$54.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.